44.201.94.72
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Autoimmune

FDA approves sutimlimab for cold agglutinin disease

The U.S. Food and Drug Administration (FDA) has approved sutimlimab-jome (Enjaymo; Sanofi) to decrease the need for red blood cell transfusion due to hemolysis in adults with cold agglutinin disease (CAD), a rare type of anemia, according to a company press release. This is the first approved treatment for CAD....

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-